Genenta Science S.p.A. (NasdaqCM: GNTA)
Health Care · Biotechnology · IT
$0.63
-0.01% today · -80.5% 1Y
Genenta Science S.p.A. (NasdaqCM: GNTA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $30.38M and employs 9 people.
Over the last twelve months the share price has lost 80.5%, trading between 0.55 and 10.00.
Tweenvest scores Genenta Science S.p.A. across four factors: quality 45/100, value 23/100. Its strongest factor is quality.
GNTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.38M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.33
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- $10.00
- 52-week low
- $0.55
- Avg volume (3M)
- —
- Shares outstanding
- 48.22M
- Employees
- 9
- Next earnings
- —
About Genenta Science S.p.A.
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
- ISIN
- US36870W1009
- Founded
- 2014
- Listed since
- Dec 15, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sernova Biotherapeutics IncTSX: SVA | $30.70M | CA$0.12 | 0.00% |
| Raphael Pharmaceutical Inc.OTCPK: RAPH | $30.47M | $1.51 | — |
| Metagenomi Therapeutics, Inc.NasdaqGS: MGX | $30.43M | $0.81 | -1.30% |
| HLB Pep Co., Ltd.KOSDAQ: A196300 | $30.38M | ₩4,320.00 | -17.24% |
| Aligos Therapeutics, Inc.NasdaqCM: ALGS | $30.35M | $4.86 | -8.99% |
| Immunotech Biopharm LtdSEHK: 6978 | $30.29M | HK$0.39 | -4.94% |
| BriaCell Therapeutics Corp.TSX: BCT | $30.01M | CA$4.88 | -13.01% |
| Poltreg S.A.WSE: PTG | $29.79M | zł19.55 | +0.26% |
Figures last refreshed Oct 18, 2026.